skip to Global Navigation Bar skip to main content


homeHome > About Us > Recruitment > News

News

News Content
The U.S. 3-phase clinical results of ‘Jeuveau’ is published on an SCI-level international journal
Date 2019-03-25 Hit 1493
list
News List
Prev Daewoong Pharmaceutical acquires the sales rights for Vivotif, an orally injected typhoid fever vaccine.
Next Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia